22nd Century Group, Inc. Securities Litigation

If you purchased a significant amount of shares of 22nd Century Group, Inc (AMEX: XXII), you have certain options. Investors should register for updates.


Lawsuit Overview

Defendant:22nd Century Group, Inc
Date Filed:January 21st, 2019
Sector:Consumer Non-Durables

According to the Complaint, 22nd Century Group, Inc. ("22nd Century" or the "Company") provides technology that increases or decreases the nicotine levels and other nicotinic alkaloids in tobacco plants, and cannabinoids in
hemp/cannabis plants through genetic engineering and plant breeding.

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) 22nd Century's stock was prone to manipulation through paid stock promotions; (2) such conduct would subject 22nd Century to heightened regulatory scrutiny by the Securities and Exchange Commission; and (3) consequently, 22nd Century's public statements were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Sign up for free to create a personalized portfolio with tracking and e-mail alerts for 22nd Century Group, Inc

First Identified Complaint

Matthew Bull, et al. v. 22nd Century Group, Inc., et al.

Date Filed:January 21st, 2019
Class Period Start:February 18th, 2016
Class Period End:October 25th, 2018
First Identified Complaint Filings
#Document TitleFiling Date